Skip to main content
AAN.com
Articles
June 1, 1993

Prevalence of diabetic neuropathy with somatic symptoms
A door‐to‐door survey in two Sicilian municipalities

June 1993 issue
43 (6) 1115

Abstract

In a door-to-door survey conducted in two municipalities of Sicily, we ascertained the prevalence of diabetic neuropathy. Our case-finding was restricted to subjects with somatic symptoms. During phase 1, we administered a screening instrument for peripheral neuropathy to 14,540 persons residing in Santa Teresa di Riva (Messina Province) and Terrasini (Palermo Province). During phase 2, neurologists evaluated those subjects who had screened positive. Diagnoses were based on clinical criteria only, and were reviewed by an adjudication panel. We found 39 persons (27 women, 12 men) affected by diabetic neuropathy. The crude prevalence, as of November 1, 1987, was 268.2 cases per 100,000 population. The prevalence increased with advancing age for both sexes and was consistently higher in women. The most common type was distal symmetric polyneuropathy. The median time between diagnosis of diabetes mellitus and onset of diabetic neuropathy was 8 years, and almost all identified persons with diabetic neuropathy were under treatment for diabetes mellitus.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 43Number 6June 1993
Pages: 1115
PubMed: 8170554

Publication History

Published online: June 1, 1993
Published in print: June 1993

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

G. Savettieri, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
W. A. Rocca, MD, MPH
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
G. Salemi, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
F. Meneghini, ScD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
F. Grigoletto, ScD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
L. Morgante, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
A. Reggio, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
V. Costa, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
M. A. Coraci, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
R. Di Perri, MD
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.
For the Sicilian Neuro-Epidemiologic Study (SNES) Group
Department of Neurology (Drs. Savettieri, Salemi, and Costa), University of Palermo; Italian Multicentre Study on Dementia, SMID Centre (Dr. Rocca), Florence; Department of Biostatistics and Epidemiology (Dr. Meneghini), Fidia Research Laboratories, Abano Terme; Department of Statistical Sciences (Dr. Grigoletto), University of Padua; Department of Neurology (Drs. Morgante, Di Perri, and Coraci), University of Messina; and Department of Neurology (Dr. Reggio), University of Catania, Italy.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1869, 5, (166714), (2023).https://doi.org/10.1016/j.bbadis.2023.166714
    Crossref
  2. Regression Trees and Ensemble for Multivariate Outcomes, Sankhya B, 85, 1, (77-109), (2023).https://doi.org/10.1007/s13571-023-00301-z
    Crossref
  3. Main metabolic and toxic polyneuropathies in clinical practice, Meditsinskiy sovet = Medical Council, 19, (134-146), (2021).https://doi.org/10.21518/2079-701X-2021-19-134-146
    Crossref
  4. A systematic review and meta-analysis of the serum lipid profile in prediction of diabetic neuropathy, Scientific Reports, 11, 1, (2021).https://doi.org/10.1038/s41598-020-79276-0
    Crossref
  5. The metabolic drivers of neuropathy in India, Journal of Diabetes and its Complications, 34, 10, (107653), (2020).https://doi.org/10.1016/j.jdiacomp.2020.107653
    Crossref
  6. A 55-Year-Old Diabetic Woman with Feet Pain, Practical Chronic Pain Management, (319-329), (2020).https://doi.org/10.1007/978-3-030-46675-6_40
    Crossref
  7. Time to Onset of Paresthesia Among Community Members Exposed to the World Trade Center Disaster, International Journal of Environmental Research and Public Health, 16, 8, (1429), (2019).https://doi.org/10.3390/ijerph16081429
    Crossref
  8. Prevalence of common causes of neuropathic pain in Korea: population-based observational study, Journal of International Medical Research, 48, 7, (030006051988810), (2019).https://doi.org/10.1177/0300060519888102
    Crossref
  9. SVM–CART for disease classification, Journal of Applied Statistics, 46, 16, (2987-3007), (2019).https://doi.org/10.1080/02664763.2019.1625876
    Crossref
  10. Randomized controlled trial of a clinical decision support system for painful polyneuropathy, Muscle & Nerve, 61, 5, (640-644), (2019).https://doi.org/10.1002/mus.26774
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share